I now have comprehensive, textbook-sourced content with images. Here is the complete, well-organized answer for 2nd year BDS pathology:
Hypertension - Pathology (2nd Year BDS)
Based on Robbins & Kumar Basic Pathology and Robbins, Cotran & Kumar Pathologic Basis of Disease
1. Definition and Classification
Hypertension is defined as sustained diastolic pressure >80 mm Hg or sustained systolic pressure >120 mm Hg. It affects approximately 40-50% of the general population and is a major risk factor for atherosclerosis, congestive heart failure, stroke, and renal failure.
Types:
| Type | Frequency | Key Feature |
|---|
| Primary (Essential/Idiopathic) | 90-95% of cases | No identifiable cause; multifactorial |
| Secondary | 5-10% of cases | Identifiable underlying disease |
Synonyms for primary hypertension: Essential, idiopathic, benign hypertension (though "benign" is a misnomer - it is neither benign nor essential).
2. Blood Pressure Regulation (Physiology Review)
Understanding the regulation is key to understanding why hypertension occurs:
- Blood pressure = Cardiac output × Peripheral vascular resistance
- Cardiac output is determined by heart rate and stroke volume (influenced by blood volume)
- Blood volume is regulated mainly by renal sodium excretion/reabsorption
- The Renin-Angiotensin-Aldosterone System (RAAS) is the central regulator
RAAS pathway:
Low BP → Kidney secretes Renin → Renin cleaves Angiotensinogen (liver) → Angiotensin I → ACE in lung endothelium → Angiotensin II → (a) Vasoconstriction + (b) Aldosterone release from adrenal → Na⁺ and water reabsorption → increased blood volume → increased BP
Counterbalancing this are natriuretic peptides (ANP from atria, BNP from brain/ventricles) which promote vasodilation and Na⁺ excretion.
3. Causes of Secondary Hypertension
| System | Causes |
|---|
| Renal | Acute/chronic glomerulonephritis, polycystic kidney disease, renal artery stenosis (renovascular HTN), renin-secreting tumors |
| Endocrine | Cushing syndrome, primary aldosteronism, pheochromocytoma, acromegaly, hypothyroidism, hyperthyroidism, oral contraceptives |
| Cardiovascular | Coarctation of the aorta, polyarteritis nodosa |
| Neurologic | Increased intracranial pressure, obstructive sleep apnea |
Renovascular hypertension mechanism: Renal artery stenosis → decreased glomerular flow → RAAS activation → increased vasoconstriction + blood volume.
Primary hyperaldosteronism (idiopathic or adrenal adenoma) is one of the most frequent causes of secondary hypertension.
Rare single-gene disorders:
- Defects in aldosterone metabolism enzymes (aldosterone synthase, 11β-hydroxylase, 17α-hydroxylase) → excess aldosterone → salt/water retention
- Liddle syndrome - mutation in epithelial Na⁺ channel (ENaC-γ) → exaggerated distal tubular Na⁺ reabsorption
4. Pathogenesis of Primary (Essential) Hypertension
Primary hypertension is a complex, multifactorial disorder involving both genetic and environmental factors. The final common pathway is:
Increased blood volume + Increased peripheral vascular resistance (both often linked to increased Na⁺ reabsorption by the kidney)
Genetic Factors:
- Twin studies and genome-wide association studies (GWAS) confirm strong genetic contribution
- 500+ genetic variants are identified, each with small individual effects
- Polymorphisms affecting sodium resorption, the RAAS, aldosterone pathways, and the adrenergic nervous system all play roles
Environmental Factors:
- Dietary sodium - excess Na⁺ increases blood volume
- Obesity - promotes insulin resistance, activates the sympathetic nervous system, and stimulates Na⁺ reabsorption
- Stress - adrenergic system activation increases cardiac output and vascular resistance
Key pathophysiologic mechanisms:
- Reduced renal Na⁺ excretion at any given blood pressure level ("resetting of the pressure-natriuresis curve") - central mechanism
- RAAS dysregulation - inappropriately elevated renin/angiotensin II activity
- Increased sympathetic nervous system activity
- Defects in natriuretic peptide signaling
- Endothelial dysfunction - reduced nitric oxide (vasodilator) production
5. Vascular Pathology in Hypertension
Hypertension causes two main types of vascular injury. Both are visible histologically and are exam-important.
A. Hyaline Arteriolosclerosis (Benign HTN)
- Seen in primary hypertension (also in diabetes and normal aging, but more generalized/severe in HTN)
- Arteriolar walls show homogeneous, pink (eosinophilic), hyaline thickening with luminal narrowing
- Caused by:
- Plasma protein leakage across injured endothelial cells
- Increased ECM production by smooth muscle cells (SMCs) in response to chronic hemodynamic stress
- In the kidney → nephrosclerosis (diffuse vascular compromise + glomerular scarring)
B. Hyperplastic Arteriolosclerosis (Malignant/Severe HTN)
- Seen in severe/malignant hypertension
- Vessels show concentric, laminated "onion-skin" thickening with luminal narrowing
- Laminations consist of SMCs + thickened, reduplicated basement membrane
- In malignant hypertension: accompanied by fibrinoid deposits and vessel wall necrosis (necrotizing arteriolitis), especially prominent in the kidney
Histology (Robbins Fig. 8.4):
Fig. A: Hyaline arteriolosclerosis - arteriolar wall thickened with amorphous proteinaceous material, markedly narrowed lumen. Fig. B: Hyperplastic arteriolosclerosis ("onion-skinning", arrow) causing luminal obliteration (PAS stain)
6. Consequences / End-Organ Damage
A. Heart - Hypertensive Heart Disease
Left-sided (Systemic) Hypertensive Heart Disease:
Diagnostic criteria:
- Left ventricular hypertrophy (LVH) in the absence of other cardiovascular pathology
- History or evidence of hypertension in other organs
Gross morphology:
- Heart weight >500 g (normal 320-360 g in a 60-70 kg individual)
- LV wall thickness >2.0 cm (normal 1.2-1.4 cm)
- Concentric hypertrophy (pressure overload, NO early dilation)
- Late stage: LV dilation when heart fails
Microscopy:
- Increased transverse diameter of myocytes
- "Boxcar nuclei" (prominent nuclear enlargement and hyperchromasia)
- Intercellular fibrosis
Clinical features:
- Usually asymptomatic initially (detected by BP measurement, ECG/echo)
- Later: atrial fibrillation (from left atrial dilation), congestive heart failure (CHF)
- Increased risk of ventricular arrhythmias, sudden cardiac death, MI, and stroke
- HTN control can cause regression of hypertrophy
Right-sided (Cor Pulmonale): Right ventricular hypertrophy/dilation from pulmonary hypertension (due to lung disorders, not directly systemic HTN)
B. Kidney - Nephrosclerosis
- Hyaline arteriolosclerosis in renal arterioles → reduced blood flow → ischemic glomerular damage and tubular atrophy
- Gross: bilaterally contracted, granular kidneys
- Result: chronic renal failure
C. Brain
- Stroke (cerebral hemorrhage or infarction)
- Hypertension is the single most important risk factor for hemorrhagic stroke
- Can also cause lacunar infarcts and multi-infarct dementia
D. Blood Vessels (Large arteries)
- Accelerates atherosclerosis
- Promotes aortic dissection and aortic aneurysm
- Cerebrovascular hemorrhage
7. Malignant Hypertension
- Rapidly progressive, severe form
- BP typically >180/120 mm Hg
- Characterized by:
- Hyperplastic arteriolosclerosis with fibrinoid necrosis
- Necrotizing arteriolitis (especially kidney)
- Papilledema
- Acute renal failure
- Encephalopathy
- Medical emergency
8. Summary - Key Concepts Table
| Feature | Detail |
|---|
| Definition | Sustained BP >120/80 mm Hg |
| Most common type | Primary/Essential (90-95%) |
| Pathogenesis | Increased Na⁺ reabsorption → RAAS activation → ↑BP |
| Benign HTN vascular lesion | Hyaline arteriolosclerosis ("pink, glassy" wall thickening) |
| Malignant HTN vascular lesion | Hyperplastic arteriolosclerosis ("onion-skin") + fibrinoid necrosis |
| Cardiac effect | LV concentric hypertrophy → "Boxcar nuclei" on microscopy |
| Renal effect | Nephrosclerosis (arteriolar narrowing + glomerular scarring) |
| Major risk for | Atherosclerosis, stroke, heart failure, renal failure |
Oral Pathology Relevance (BDS Specific)
Hypertension is relevant to dental practice:
- Many antihypertensive drugs (Ca-channel blockers like nifedipine, amlodipine) cause gingival enlargement (drug-induced gingival overgrowth)
- Patients on antihypertensives need BP monitoring before dental procedures
- Hypertension promotes periodontal disease (shared risk factors - inflammation, endothelial dysfunction)
- Stress of dental procedures can acutely elevate blood pressure
Sources: Robbins & Kumar Basic Pathology (Robbins Pathology), pp. 311-315, 362-363 | Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 445-448, 463